Trial reportBMC complementary medicine and therapies2025
Mobilization with movement plus exercise versus exercise alone for patients with central sensitization associated with chronic subacromial pain syndrome: a sham-controlled randomized clinical trial.
Trial report in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05524870 (Movement With Mobilization Technic Plus Exercising Versus Exercising Alone for Central Sensitization in Patients With Subacromial Pain), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Movement With Mobilization Technic Plus Exercising Versus Exercising Alone for Central Sensitization in Patients With Subacromial Pain: a Sham-controlled Randomized Clinical Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficacy of mobilization with movement (MWM) in addressing central sensitization and widespread mechanical hyperalgesia in patients with subacromial pain syndrome (SPS) remains unclear. This study aimed to evaluate the efficacy of MWM combined with exercise in improving the Central Sensitization Inventory (CSI) score, widespread mechanical hyperalgesia, and functional disability in patients with central sensitization associated with SPS.
methodsThis study was designed as a single-blind, randomized, sham-controlled trial. Sixty-three adult patients with central sensitization associated with chronic SPS were randomly assigned to three groups (MWM, Sham MWM, and Control) using a permuted block randomization method. Outcomes were assessed at baseline, post-intervention (after three weeks), and at a three-month follow-up. The outcome measures included the CSI, pressure pain threshold measurements (PPT), and the Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (Q-DASH). The CSI was used to assess emotional and somatic symptoms associated with central sensitization; PPTs evaluated local and widespread pain hypersensitivity; and the Q-DASH assessed upper extremity physical function and symptoms. A two-factor repeated-measures analysis of variance (group × time) with Bonferroni post-hoc correction was performed to analyze the main outcome variables.
resultsAt baseline, there were no significant differences in age, gender, or clinical characteristics among the groups. At the post-intervention stage, MWM combined with exercise did not result in superior improvements in CSI scores, local-widespread PPTs, or functional disability compared to sham-MWM or exercise alone (p > 0.05 for all). However, at the three-month follow-up, the MWM group showed significantly greater improvements in PPTs at the deltoid [p = 0.042, mean difference (MD) (95% CI): 0.6 (0.0 to 1.2)], brachioradialis [p = 0.028, MD (95% CI): 0.9 (0.1 to 1.7)], rectus femoris [p = 0.008, MD (95% CI): 0.9 (0.2 to 1.8)], and tibialis anterior [p = 0.029, MD (95% CI): 0.7 (0.1 to 1.4)] compared to the sham-MWM group. Additionally, significant differences were also found between the MWM and control groups in PPTs at the deltoid [p < 0.001, MD (95% CI): 1.0 (0.4 to 1.5)], brachioradialis [p = 0.012, MD (95% CI): 1.0 (0.2 to 1.8)], rectus femoris [p = 0.005, MD (95% CI): 0.9 (0.3 to 1.6)], and tibialis anterior [p = 0.022, MD (95% CI): 0.8 (0.1 to 1.5)].
conclusionsIn patients with central sensitization associated with chronic subacromial pain syndrome, the combination of mobilization with movement and exercise did not result in significant short-term (three-week) improvements in emotional and somatic symptoms of central sensitization or widespread pain hypersensitivity, compared to sham mobilization with movement plus exercise or exercise alone. However, this intervention led to greater mid-term (three-month) reductions in both local and widespread mechanical hyperalgesia in these patients.
trial registrationClinicalTrials.gov (Clinical trial number: NCT05524870, First Submitted Date: 15.02.2022).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.